Exercise Programs for Women With Polycystic Ovary Syndrome
Compares digital and face-to-face exercise programs in women with polycystic ovary syndrome.
Key facts
- Who runs it
- Biruni University
- Where
- Istanbul, TürkiyeSee the site
- Trial code
- Registry title
- Exercise Programs in Women With PCOS
- Status
- Not yet recruiting
- People taking part
- 33 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 25 Mar 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Face-to-face exercise
- Digital rehabilitation
- Record updated
- 17 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18-40 with polycystic ovary syndrome (PCOS) who can join video sessions online. It tests exercise programs over 8 weeks.
- Age
- 18 to 40 years
- Sex
- Women only
- Disease stage
- PCOS diagnosed by the Rotterdam criteria (at least two of three: irregular periods with rare or no ovulation, signs of high male hormones, polycystic ovaries on ultrasound) and confirmed by a specialist doctor
- Earlier treatment
- No hormonal contraceptive, insulin-sensitizing or blood pressure drugs in the last 3 months; no weight-loss medicine or structured diet program during the study
Main reasons for not taking part
- Pregnant or breastfeeding
- Acute infection
- Uncontrolled irregular heartbeat, high blood pressure, diabetes or unstable angina
- Leg injury or surgery in the last six months
- Severe obesity (BMI above 40 kg/m2)
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Women aged 18-40 years diagnosed with PCOS according to the Rotterdam criteria (Rotterdam, 2003) and by a specialist physician; The presence of at least two of the following three criteria will be considered sufficient for a diagnosis of PCOS according to the Rotterdam criteria: (i) history of irregular menstruation with oligo/anovulation, (ii) clinical and/or biochemical signs of hyperandrogenism, (iii) detection of polycystic ovary images on ultrasonography
- Having sufficient technological skills to participate in the treatment online (ability to use video conferencing applications)
- Voluntary participation in the study
Who cannot take part
- Individuals receiving medical treatment for weight loss (liraglutide, semaglutide, orlistat, bupropion/naltrexone, thizzpatide) or participating in a structured diet program during the study period
- Individuals taking antihypertensive, insulin-sensitizing, or hormonal contraceptive drugs in the last 3 months
- Individuals with acute infections
- Uncontrolled arrhythmia, hypertension, diabetes, and unstable angina pectoris
- Individuals with a history of lower extremity injury or surgery in the last six months
- Pregnant and breastfeeding women
- Impaired cooperation, orthopedic and neurological problems that may hinder assessment and program participation
- Individuals with class III obesity according to WHO classification (BMI > 40 kg/m2) (WHO, 2000)
- Individuals actively participating in another exercise program
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in Türkiye
- Biruni UniversityIstanbul, TürkiyeContact: Buket Akıncı, Prof. Dr.No longer taking part
About the trial
What the trial wants to find out
This study aims to investigate the effectiveness of a digital rehabilitation-supported combined exercise program in women with Polycystic Ovary Syndrome (PCOS). Participants aged 18-40 years will be randomly assigned to one of three groups: a digital rehabilitation group, a face-to-face exercise group, and a physical activity counseling group. The intervention will last 8 weeks, with exercise performed three times per week. Outcomes will include DNA methylation, hormonal and metabolic parameters, anthropometric measurements, body composition, muscle strength, basal metabolic rate, physical activity level, quality of life, menstrual cycle regularity, exercise adherence and satisfaction.
The 3 groups in the trial
- Face-to-face Exercise GroupTreatment being tested
Participants will perform combined exercise sessions with a physiotherapist, three times per week for 8 weeks.
Treatment: Face-to-face exercise
- Digital Rehabilitation GroupTreatment being tested
Participants will perform a combined exercise program by digital rehabilitation tools with physiotherapist, three times per week for 8 weeks.
Treatment: Digital rehabilitation
- Physical Activity Counseling GroupNo study treatment, for comparison
Participants will receive physical activity recommendations.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Investigation of the Effectiveness of a Digital Rehabilitation-Supported Combined Exercise Program in the Management of Polycystic Ovary Syndrome
- Plain-language title
- Exercise Programs for Women With Polycystic Ovary SyndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07509762, who can take part
- Record updated
- 17 June 2026